LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

Search

Codexis Inc

Chiusa

SettoreSettore sanitario

2.42 -0.41

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.41

Massimo

2.44

Metriche Chiave

By Trading Economics

Entrata

7.4M

-13M

Vendite

7.8M

15M

EPS

-0.16

Margine di Profitto

-86.587

Dipendenti

188

EBITDA

7.6M

-13M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+160.49% upside

Dividendi

By Dow Jones

Utili prossimi

30 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-11M

221M

Apertura precedente

2.83

Chiusura precedente

2.42

Notizie sul Sentiment di mercato

By Acuity

12%

88%

13 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Codexis Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

12 set 2025, 22:41 UTC

I principali Market Mover

GlucoTrack Stock Falls on Plans to Sell $3 Million Note

12 set 2025, 16:04 UTC

I principali Market Mover

Upexi Shares Climb on Solana Gains

12 set 2025, 15:03 UTC

I principali Market Mover

Allied Gaming & Entertainment Shares Surge Following Crypto Investments

13 set 2025, 08:20 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

12 set 2025, 20:50 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

12 set 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

12 set 2025, 20:09 UTC

Utili

Correction to Opendoor Is Sliding. Don't Call It a Meme Stock, Says New Chairman. -- Barrons.com

12 set 2025, 19:23 UTC

Discorsi di Mercato

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12 set 2025, 19:16 UTC

Discorsi di Mercato

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12 set 2025, 19:03 UTC

Discorsi di Mercato

Natural Gas Futures Held Back By Plump Inventories -- Market Talk

12 set 2025, 18:59 UTC

Discorsi di Mercato

Dollar Pares Gains as Economy Keeps Showing Signs of Cooling -- Market Talk

12 set 2025, 18:38 UTC

Discorsi di Mercato
Utili

Adobe Seen Reaching Turning Point in AI Cycle -- Market Talk

12 set 2025, 18:33 UTC

Discorsi di Mercato

U.S. Oil Rig Count Rises By 2 to 416 -- Market Talk

12 set 2025, 18:22 UTC

Discorsi di Mercato

Canada's Divergence With US On Capex Spending is 'Appalling' -- Market Talk

12 set 2025, 16:56 UTC

Discorsi di Mercato

Renewable Fuels Association Calls for Nationwide E15 Following WASDE -- Market Talk

12 set 2025, 16:22 UTC

Utili

Adobe Earnings Were 'Solid.' Long-Term Growth Concerns Remain. -- Barrons.com

12 set 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

12 set 2025, 16:19 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

12 set 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

12 set 2025, 16:11 UTC

Utili

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

12 set 2025, 15:37 UTC

Discorsi di Mercato

Gold Holds Near All-Time Highs Ahead of Fed Meeting Next Week -- Market Talk

12 set 2025, 15:22 UTC

Discorsi di Mercato

European Gas Lifted by Geopolitical Risks But Storage Levels Ease Supply Fears -- Market Talk

12 set 2025, 15:07 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

12 set 2025, 14:34 UTC

Discorsi di Mercato

Russia Sanctions Put Bid Back in Oil -- Market Talk

12 set 2025, 14:10 UTC

Discorsi di Mercato

Inflation Report Unlikely to Dissuade Canada From Rate Cut -- Market Talk

12 set 2025, 13:58 UTC

Discorsi di Mercato

Dollar Could Rise if Fed Sounds Cautious on Rate Cuts -- Market Talk

12 set 2025, 13:58 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Super Micro, Adobe, Microsoft, Figure Technology, and More -- Barrons.com

12 set 2025, 13:57 UTC

Utili

AbbVie Stock Hit a Record on 'Big Win' for Blockbuster Drug. The Case for Buying In. -- Barrons.com

12 set 2025, 13:56 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

12 set 2025, 13:56 UTC

Discorsi di Mercato

Canadian Dollar Faces Further Weakness Vs Non-U.S. Dollar Currencies -- Market Talk

Confronto tra pari

Modifica del prezzo

Codexis Inc Previsione

Obiettivo di Prezzo

By TipRanks

160.49% in crescita

Previsioni per 12 mesi

Media 6.33 USD  160.49%

Alto 11 USD

Basso 3 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Codexis Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

5 ratings

3

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

2.25 / 2.53Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

13 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
help-icon Live chat